Cancer Research Meeting Calendar  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 8565, September 15, 2007. doi: 10.1158/0008-5472.CAN-07-1593
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blanc, V.
Right arrow Articles by Davidson, N. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blanc, V.
Right arrow Articles by Davidson, N. O.

Molecular Biology, Pathobiology, and Genetics

Deletion of the AU-Rich RNA Binding Protein Apobec-1 Reduces Intestinal Tumor Burden in Apcmin Mice

Valerie Blanc1, Jeffrey O. Henderson1, Rodney D. Newberry1, Yan Xie1, Soo-Jin Cho1, Elizabeth P. Newberry1, Susan Kennedy1, Deborah C. Rubin1,3, Hanlin L. Wang2, Jianyang Luo1 and Nicholas O. Davidson1,3

Departments of 1 Medicine, 2 Pathology and Immunology, and 3 Pharmacology and Molecular Biology, Washington University School of Medicine, St. Louis, Missouri

Requests for reprints: Nicholas O. Davidson, Division of Gastroenterology, Washington University School of Medicine, Campus Box 8124, 660 South Euclid Avenue, St. Louis, MO 63110. Phone: 314-362-2027; Fax: 314-362-2033; E-mail: nod{at}wustl.edu.

The RNA-specific cytidine deaminase apobec-1 is an AU-rich RNA binding protein that binds the 3' untranslated region (UTR) of cyclooxygenase-2 (Cox-2) mRNA and stabilizes its turnover in vitro. Cox-2 overexpression accompanies intestinal adenoma formation in both humans and mice. Evidence from both genetic deletion studies as well as from pharmacologic inhibition has implicated Cox-2 in the development of intestinal adenomas in experimental animals and in adenomas and colorectal cancer in humans. Here, we show that small intestinal adenoma formation is dramatically reduced in compound Apcmin/+ apobec-1–/– mice when compared with the parental Apcmin/+ strain. This reduced tumor burden was found in association with increased small intestinal apoptosis and reduced proliferation in small intestinal crypt-villus units from compound Apcmin/+ apobec-1–/– mice. Intestinal adenomas from compound Apcmin/+ apobec-1–/– mice showed a <2-fold increase in Cox-2 mRNA abundance and reduced prostaglandin E2 content compared with adenomas from the parental Apcmin/+ strain. In addition, there was reduced expression in adenomas from compound Apcmin/+ apobec-1–/– mice of other mRNAs (including epidermal growth factor receptor, peroxisome proliferator–activated receptor {delta}, prostaglandin receptor EP4, and c-myc), each containing the apobec-1 consensus binding site within their 3'-UTR. Adenovirus-mediated apobec-1 introduction into HCA-7 (colorectal cancer) cells showed a dose-dependent increase in Cox-2 protein and stabilization of endogenous Cox-2 mRNA. These findings suggest that deletion of apobec-1, by modulating expression of AU-rich RNA targets, provides an important mechanism for attenuating a dominant genetic restriction point in intestinal adenoma formation. [Cancer Res 2007;67(18):8565–73]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Xie, V. Blanc, T. A. Kerr, S. Kennedy, J. Luo, E. P. Newberry, and N. O. Davidson
Decreased Expression of Cholesterol 7{alpha}-Hydroxylase and Altered Bile Acid Metabolism in Apobec-1-/- Mice Lead to Increased Gallstone Susceptibility
J. Biol. Chem., June 19, 2009; 284(25): 16860 - 16871.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.